Elevated serum interleukin-15 levels in systemic lupus erythematosus

Area of Science:

• Immunology
• Rheumatology

Background:

• Interleukin-15 (IL-15) is a cytokine with roles in immune regulation, including T cell apoptosis and cytokine induction.
• IL-15 is implicated in rheumatoid arthritis pathogenesis, potentially amplifying inflammation via TNF-alpha.
• Systemic lupus erythematosus (SLE) is characterized by apoptosis dysregulation and altered cytokine production.

Purpose of the Study:

• To determine serum IL-15 levels in SLE patients.
• To assess the relationship between IL-15 levels, TNF-alpha levels, and SLE disease activity.

Main Methods:

• Serum IL-15 and TNF-alpha levels were measured using ELISA in 20 SLE patients and 10 controls.
• SLE disease activity was assessed using the SLE Disease Activity Index (SLEDAI) and various laboratory markers.
• Paired samples were collected during active disease and after 4 weeks of treatment.

Main Results:

• SLE patients exhibited significantly higher serum IL-15 levels compared to controls.
• Elevated IL-15 levels did not correlate with SLEDAI or other laboratory indices of disease activity.
• Changes in IL-15 levels did not correlate with TNF-alpha changes, while TNF-alpha reflected disease activity.

Conclusions:

• Serum IL-15 is elevated in SLE patients but does not correlate with disease activity.
• IL-15 is unlikely to be the primary driver of TNF-alpha production in SLE patients.